A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.
Phase 4
Completed
- Conditions
- Diabetes
- Registration Number
- NCT00162344
- Lead Sponsor
- Lantheus Medical Imaging
- Brief Summary
The study is designed to see if stress heart imaging can be used as a screening exam in patients with diabetes and risk factors of developing of coronary artery disease and experiencing future cardiac events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 205
Inclusion Criteria
- History of diabetes for at least 5 years, with a least 2 risk factors (i.e. hypertension, elevated cholesterol levels, history of or current smoker, obese, family history of heart disease) & atypical chest pain.
Read More
Exclusion Criteria
- Typical chest pain being treated with medication, unable to exercise, previous confirmed heart disease
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Examine the prevalence of ischemic heart disease in population of patients with diabetes mellitus and atypical chest pain.
- Secondary Outcome Measures
Name Time Method Determine the accuracy of myocardial perfusion imaging (MPI) and exercise tolerance testing (ETT) for the detection of coronary artery disease (CAD) in a subset of patients undergoing clinically indicated coronary angiography. Determine the relative value of ETT, Duke Treadmill Score (DTS), MPI, ejection fraction (EF), clinical risk factors, and C-Reactive Protein (CRP) values for identifying patients at risk for cardiac events.
Trial Locations
- Locations (1)
Local Institution
🇨🇦Montreal, Quebec, Canada